Background: Medication is an important element of therapeutic strategies for ADHD. While
medications for ADHD are generally well‐tolerated, there are common, although less …

Objective: To systematically review, synthesize, and appraise available evidence,
connecting adult ADHD with somatic disease. Method: Embase, Psychinfo, and Medline …

Sleep problems in adolescence have been identified as an international public health issue.
Over the past few decades, notable advances have been made in our understanding of the …

Individuals with attention-deficit/hyperactivity disorder (ADHD) frequently have sleep
disturbances, daytime sleepiness, and/or circadian rhythm abnormalities. This article …

Objective To provide evidence-or consensus-based recommendations concerning the
assessment and management of sleep problems in youths with attention-deficit/hyperactivity …

Rationale Psychostimulants, including methylphenidate (MPH), are the mainstay of
pharmacotherapy for attention-deficit/hyperactivity disorder (ADHD) in adults. Even though …

Epidemiological evidence suggests that one's risk of being diagnosed with a
neurodevelopmental disorder (NDD)—such as autism, ADHD, or schizophrenia—increases …

Atomoxetine, a selective norepinephrine (NE) reuptake inhibitor, was approved for attention
deficit/hyperactivity disorder (ADHD) treatment in children, adolescents and adults. We …

CONTEXT: Mixed findings exist on whether stimulant medications alter youth sleep.
OBJECTIVE: To determine the effect of stimulant medications on sleep. DATA STUDIES …

Background Biological mechanisms underlying symptom and prognostic heterogeneity in
Attention-Deficit/Hyperactivity Disorder (ADHD) are unclear. Sleep impacts neurocognition …